recombinant vaccinia-CEA-MUC-1-TRICOM vaccine
Term · Oncology and biomedicine · MLC-T-ONC-007262
A cancer vaccine made with a form of vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins, including the tumor markers called CEA and MUC-1, that may help immune cells in the body kill tumor cells. Also called inalimarev and PANVAC-V.
| Identifier | MLC-T-ONC-007262 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | inalimarev; PANVAC-V |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007262",
"term": "recombinant vaccinia-CEA-MUC-1-TRICOM vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine made with a form of vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins, including the tumor markers called CEA and MUC-1, that may help immune cells in the body kill tumor cells. Also called inalimarev and PANVAC-V.",
"synonyms": [
"inalimarev",
"PANVAC-V"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-vaccinia-cea-muc-1-tricom-vaccine/"
}
Record 14,221 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.